Liraglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist that can effectively control blood glucose and improve metabolism, and it has a significant effect on reducing liver inflammation, steatosis, and fibrosis. This evidence concerns the gene GLP1R and steatosis.